Members

Our members: deep expertise and invaluable support

CQDM members

Companies, researchers, academic centres, and collaborators contribute to facilitating biopharmaceutical innovation by accelerating the translation and transformation of innovative technologies into solutions meeting unmet medical needs. CQDM members bring together key players focused on innovation, collaboration, and consolidation of the biopharmaceutical sector. Three types of membership exist at CQDM. We invite you to consult them and find the one that best suits your objectives and needs.

“Network” members

CQDM’s Network” members benefit from specific advantages helping them in their search for notoriety and consolidation in the ecosystem. Become a Network” member of CQDM and be able to:

Facilitate your networking: several advantages during exclusive CQDM events offered to the ecosystem.

Consolidate your visibility: exposure of your organization on our platforms (audience of 10,000 subscribers) and many events.

Facilitate your search for financing: guidance and personalized support from our advisors when seeking financing via government programs.

Facilitate your contact: with researchers, SMEs, and large global pharmaceutical companies to develop your innovations.

Increase your impact: in the biopharma innovation ecosystem, thanks to the adapted and continuous support of CQDM.

To become a “Network” member, click the button below. The fee is $150 per year, taxes included.
 

 


 

RNA Technologies and Therapeutics provides off-the shelf preclinical grade and high-quality codon optimized mRNA, and we also offer custom made mRNA in multiple scales (e.g., 1mg to 1g). Our business model encompasses co-development of mRNA products/therapeutics and have our internal research program pertaining to novel modification, extension of mRNA half-life, expression, and optimization of mRNA therapeutics. The company is also working with a couple of cGMP providers while we are building our own small-scale cGMP facility.

More information on their website: https://www.rnatechnologies.com/

Nanobrand is an enterprise producing Gold and Silver Nanoparticles, offering a complete R&D, formulation, and commercial manufacturing of nano-Gold for the use in Life Science applications such as in rapid diagnostic tests, as nano-vectors for transportation of active ingredients in therapeutics and gene therapy, in medical imaging, photothermal therapy, etc. We also offer R&D, formulation, and commercial manufacturing of nano-Silver for antimicrobial/antiviral properties and other therapeutic applications.

More information on their website: https://nanobrand.com/home

The CERASP – Center of Expertise in Applied Pharmaceutical Sciences (NPO) was established in 2019 and provides turnkey, innovative, and sustainable solutions. As a partner, we also support project grant applications for research. Our experienced team excels in the fields of pharmacy, biologics/advanced therapies, animal health, and bioprocesses. We have a dedicated equipment park for research, as well as a park specifically designed for prototyping and small-batch production to facilitate project shaping. As a partner of Health Canada, we offer services in regulatory affairs and audits. Contact us to discuss how the CERASP can meet your specific needs.

More information on their website: https://cerasp.ca/

BrevisRefero is a collection of biologics CMC professionals who share a common goal – to improve and support the management of biologics programs from concept to development, GMP manufacturing and into clinical trials on behalf of our sponsor-company clients. With more than 100 years of collective technical biotech consulting experience, we work closely with our clients to develop realistic technical and strategic solutions to support the execution and delivery of biologics programs. Additionally, BrevisRefero has developed a cloud-based asset called RFP>Navigator® (www.rfpnavigator.com) that helps sponsors (innovators) run a professional RFP process to identify and select their ideal CDMO and CRO partners to enable the manufacturing and trials for Phase 1-3 clinical programs.

More information on their website: https://www.brevisrefero.com/

Two-Photon Research develops cloud-based molecular diagnostics based on photonic biosensors and high sensitivity diagnostic devices to deliver instant test results. TPR incorporates innovations in molecular science, photonics, in silico 3D modeling and generative AI.

More information on their website: https://www.twophotonresearch.com/

Rynd Biotech is a rapid urine diagnostics platform for sexually transmitted infections (STIs). We specialize in providing accurate, point-of-care testing solutions and discreet at-home testing. Our innovative technology aims to redefine STI management by automating diagnosis and prescription delivery upon positive test results.

More information on their website: https://www.ryndbiotech.com/

Cura Therapeutics is developing a first-in-class immunotherapy platform to treat a wide range of solid malignancies and infectious diseases. Our technologies harness cytokines to create multi-functional proteins with potent anti-cancer and anti-viral properties. Our lead immunotherapy (CT101) targets and synchronizes major immune system mechanisms against metastatic cancer.

More information on their website: https://www.curatherapeutics.com/

TATUM bioscience is a therapeutic company developing next-generation holistic immunotherapies for the treatment of cancers.

More information on their website: https://www.tatumbio.com/

Syka Pharma develops, imports and markets pharmaceutical products focused on easing the burden of healthcare professionals while meeting the needs of patients. We are looking for: Regulatory experts to circumvent the clinical study.

Website under construction.

Lab.Space is a trusted general contractor serving Montreal and the surrounding areas. We specialize in workspace design and construction. With over 14 years of experience, we take pride in delivering top-quality turnkey construction services that meet the most specific needs.

More information on their website: https://lab.space/

Impacts.Ca has been working in the marketing space for life science companies for over 20 years. We specialize in product-market fits (PMF), voice-of-the-customer projects (VOC), marketing strategy and market research. Our activities are exclusively in the life science space: pharmaceutical, biotechnology, medical devices, nanotechnology and healthcare companies are our main clients. We have completed more than 400 projects in over 30 countries (including the US, France, the UK, Japan, China and the Middle East).

More information on their website: https://www.impacts.ca/

Managium helps researchers in the management of their research projects. Managium manages projects of various sizes, funded by MEI-FACS, Genome Canada, CIHR, NSERC, etc. To date, Managium has been working with more than 30 projects with a total value over $200 million.

More information on their website: https://www.managium.ca/en

At Precision Analytics, we help organizations across the life sciences industry make sense of their data and move their research forward. Let us be your on-demand data science team.

More information on their website: https://www.precision-analytics.ca/

Clinical Roots offers an advanced clinical trial management solution that emphasizes rigorous data validation and seamless collaboration between research teams. This approach increases recruitment efficiency, while consolidating data reliability.

More information on their website: https://clinicalroots.com/

DendroTEK Biosciences develops and sells cutting-edge nanoparticle-based coatings designed for in vitro cultures with unparallel longevity.

More information on their website: https://dendrotek.ca/

Neopharm is a leading analytical testing laboratory serving the global life sciences industry. We combine innovation with exceptional quality and service levels powered by a dedicated team of experts to fulfill the requirements and evolving business demands of our customers. Our wide portfolio of analytical services enables us to offer a full range of solutions at every stage of the drug development and commercialization cycle.

More information on their website: https://www.neopharmlabs.com/

At sevenTM, our mission is to empower pharmaceutical and biotech companies to efficiently identify and validate more potential candidates in less time while prioritizing the reduction of toxicity and side effects.

More information on their website: https://www.seventm.com/

We power bold ideas! RBCx helps life science companies grow and have a positive impact on society by connecting them with the right individuals for their needs (experts, investors, consultants, suppliers, etc.). RBCx offers financial ideas and solutions from one of Canada's largest banks.

More information on their website: https://www.rbcx.com/

emka TECHNOLOGIES & SCIREQ offer instruments and telemetry equipment for in vivo, in vitro and ex vivo physiology, pharmacology, and toxicology studies. Used in cardiovascular, respiratory, and neurological research, our cutting-edge solutions offer remarkable precision and reproducibility, as demonstrated by over 7,500 scientific publications.

More information on their website: https://www.seventm.com/

Northern RNA is a Canadian contract development and manufacturing organization (CDMO) focused on end-to-end supply of nucleic acid-based products and services. Our offerings include Research, Regulatory Starting Material (RSM) and cGMP grade manufacturing of cap analogs, cell banks, plasmid DNA, mRNA, Lipids and more.

More information on their website: https://northernrna.com/

At St-Amour, a division of Groupe Magellan, we go beyond traditional recruitment to offer you a complete solution. We don't just find the right candidate, we also provide you with consulting services throughout the recruitment process, right up to the integration of your new employee. Magellan puts its expertise at your disposal to offer you a complete range of innovative and demanding services. Our recruiters have also worked in industry before dedicating themselves to recruitment.

More information on their website: https://www.st-amour.com/en/

Nanofacile accelerates and de-risks targeted nanomedicine R&D by providing advanced, adaptable and efficient tools to biotech innovators. Our technology aims to reduce barriers and enable the creation of transformative therapies.

More information on their website: https://www.nanofacile.bio/

Strategic planning, business governance, legal analysis and negotiation services in health and life sciences.

More information on their website: https://jflmediator.ca/fr/english

We offer an in vivo preclinical study services as well as the possibility of renting housing room.

More information on their website: https://lnbe.inrs.ca/

The Montreal Health Innovations Coordinating Center (MHICC) is a contract research organization (CRO) associated with the Montreal Heart Institute. The MHICC offers a full range of services (Phase I-IV) in the fields of cardiology, oncology, cardio-oncology, endocrinology, precision medicine, cell therapy and more. Equipped with a new platform and new digital tools, the MHICC also stands out for its ability to conduct hybrid or virtual/decentralized clinical trials. It serves the academic community, the pharmaceutical and biotech industries, and the medical device sector.

More information on their website: https://www.mhicc.org/index.php?lang=en

Sorintellis offers an AI-powered platform for analyzing the success of clinical trials and interpreting risk factors enabling the efficient planning and conduct of clinical trials.

More information on their website: https://sorintellisgroup.com/

VVector Bio is developing disruptive technologies to improve the manufacturing of cell and gene therapy viral vectors and offering research-grade production services.

More information on their website: VVector Bio

Oncodesign Services is a contract research organization (CRO) specialized in drug discovery whose mission is to contribute to the discovery of innovative therapies against cancers and serious diseases with high medical needs.

More information on their website: https://www.oncodesign-services.com/

Spectrum Pharma is a clinical trial logistics and supply chain specialist dedicated solely and exclusively to biotech offering packaging, labelling, kitting, storage and distribution services.

More information on their website: Spectrum Pharma | Pharmaceutical packaging

Simmunome untangles biological complexity by developing in silico disease models that accurately capture physiological processes to predict efficacy and safety of potential treatments. In addition, our algorithms use a comprehensive multiomic approach to discover new targets and biomarkers for a disease or a certain patient population. More information on their website: https://www.simmunome.com/

Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. Our integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. More information on their website: https://www.altasciences.com/

Membres « Projets »

CQDM’s Project” members benefit from the advantages of “Network” members, as well as the necessary support, once their collaborative research project has been accepted. This support consists of the accompaniement from the CQDM team and financing of their project via available programs. Please contact us to become Projects” members.

Contact: Mathieu Paquette at mpaquette@cqdm.org

Defence Therapeutics is a publicly listed biotechnology company working to develop the next generation of vaccines and antibody-drug conjugates using its patented platform. The core of the Defence Therapeutics platform is the ACCUM® technology, which enables the precise delivery of vaccine antigens or antibody-drug conjugates in their intact form to target cells. This makes it possible to achieve greater efficacy and potency against serious diseases such as cancer and infectious diseases.

Despite their revolutionary potential, many cutting-edge protein therapies are limited by their toxic side effects. 9Bio uses AI-guided structural biology to develop protein solutions enabling safer applications in immuno-oncology, autoimmunity, and infectious diseases.

Website: https://9bio.ca/

Our mission is to create rapid and accurate diagnostic tests to improve the prediction of effectiveness of new oncology treatments. Our multi-target protein quantification solution is compatible with the analysis of tissues but also cytological samples.

Website: coming soon.

Feldan is a biopharmaceutical company specializing in the development of treatments based on the intracellular delivery of therapeutic products. Feldan has designed the Feldan Shuttle, a proprietary peptide-based technology that can safely and effectively deliver various compounds into cells. This technology paves the way for the development of a new generation of treatments by providing access to intracellular components beyond the reach of existing drugs. Feldan’s pipeline focuses on diseases affecting the skin and lungs.

Variational AI has developed Enki, a foundation model for small molecules focusing first on kinases. Built on Variational AI’s proprietary generative AI, Enki is a platform for chemists and drug hunters to rapidly generate novel and selective leads and perform lead optimization.

Biomark has developed a cutting-edge technology platform for the early detection of lung cancer. This new technology uses mass spectrometry to measure several biomarkers present in the blood. This test has clinically demonstrated superior detection capabilities for early stages of lung cancer (stage I/II), using an artificial intelligence algorithm that is integrated into the test analysis and combines the results of the test with the clinical data of the person at risk.

Divocco AI is a medical technology company from Montreal that is reinventing perioperative and anesthetic medicine by implementing modern and automated technologies to improve the comfort and safety of patients in the operating room, in isolated peripheral centers, or in hostile conditions.

Traffick Therapeutics/therapeutiques Inc (TTI) has developed novel genomic tools (IPPER) to facilitate the identification and validation of therapeutic targets for orphan diseases. They have applied these tools to protein folding and respiratory diseases. TTI is seeking new collaborators with interesting complementary projects.

Morphocell Technologies is a Montreal-based regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissues aimed at treating severe organ deficiencies. Morphocell is developing an extensive therapeutic platform based on its allogeneic stem cell-derived engineered liver tissues.

More information on their website: https://www.morphocell.com/

Immugenia is an immuno-oncology company developing a novel approach to CAR therapy by engineering hematopoietic stem cells to treat cancer and prevent relapses. Our proprietary technology allows for the CAR to be expressed selectively in T and NK cells in order to leverage their synergistic activity against cancer.

More information on their website: https://immugenia.com/

RejuvenRx Inc. is a biotechnology company developing therapies targeting the epigenome, metabolism and cell cycle of normal and cancer stem cells to treat age-related diseases, including cancer and degenerative diseases.

More information on their website: https://rejuvenrx.com/

Raya Therapeutic is an innovative biotech company that is developing five clinical stage new chemical entities (NCEs) and unique combinations thereof for the treatment of Amyotrophic Lateral Sclerosis (ALS) which is an Orphan Indication. It is named after Raya’s President and Founder’s father who passed away of ALS in 2011.

More information on their website: https://www.rayatherapeutic.com/?lang=en

NMX is committed to becoming a world leader in discovering therapeutic drug leads for difficult-to-treat diseases. With our in-depth biophysical expertise and constant innovations, we help accelerate drug discovery programs via fragment-based strategies.

More information on their website: https://www.nmxresearch.com/

Saydi Pharmaceuticals : propelling the inhibition of MDM2-p53 interactions across numerous cancer indications. Our candidate drug SA53 is a potent small-molecule inhibitor developed for cancer treatment to inhibit MDM2-P53 interaction.

Kanyr Pharma Inc. is a privately held biotechnology company working to bring a small molecule inhibitor to phase 1B/2 clinical trial of two closely linked PTPs, PTPN1 (PTP1B) and PTPN2 (TC-PTP). This orally available compound KQ791 improves immune response against different solid cancers, alone or in synergy with checkpoint inhibitors.

More information on their website: https://kanyrpharma.com/

Neurenati Therapeutic, co-founded by researchers Rodolphe Soret and Nicolas Pilon, is a start-up company dedicated to developing a non-surgical treatment for Hirschsprung's disease, a rare condition that affects the enteric nervous system in the colon of newborns. This treatment based on a regenerative medicine approach finds its origins in the work of Professor Pilon, carried out in his laboratory at UQAM which is associated with the Center of Excellence in Research on Orphan Diseases - Courtois Foundation (CERMO-FC). Proof of concept has been established through testing in mouse models and patient tissues, demonstrating extremely promising results. Treatment involves repeated rectal administration of a growth factor-containing formulation, aimed at stimulating and supporting the development of the enteric nervous system which is otherwise absent in the colon of affected children.

Website under construction.

Epitopea is a transatlantic cancer immunotherapeutics company based in Montreal, Canada and Cambridge, UK, and a global leader in exploiting a novel class of untapped tumour-specific antigens (TSA) designed to treat a broad patient population. Our technology platform builds on our proprietary and innovative approach to identifying shared, aberrantly expressed tumour-specific antigens, known as CryptigenTM TSAs, against which we are developing accessible off-the-shelf cancer immunotherapies that will deliver durable benefits to patients.

More information on their website: https://www.epitopea.com/

Membres Pharmaceutiques

CQDM’s Pharmaceutical members can network with the academic and business research ecosystem. The close links established during CQDM’s consolidating activities have the possibility of leading to collaborations in the financing of projects corresponding to the objectives of Pharmaceutical members. Please contact us to become Pharmaceutical members via the information below.

Contact: Jesse Paterson at jpaterson@cqdm.org

Government Sponsors
Founding members of the biopharmaceutical consortium
Scroll to Top